Cargando…

Development and Validation of an Immunoassay for Tenofovir in Urine as a Real-Time Metric of Antiretroviral Adherence

BACKGROUND: Pharmacologic adherence measures were critical to the interpretation of the tenofovir (TFV)-disoproxil-fumarate/emtricitabine (TDF/FTC) PrEP trials. These measures are being incorporated into PrEP demonstration projects, but currently-available metrics in plasma, cells, hair or urine inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gandhi, Monica, Bacchetti, Peter, Rodrigues, Warren C., Spinelli, Matthew, Koss, Catherine A., Drain, Paul K., Baeten, Jared M., Mugo, Nelly R., Ngure, Kenneth, Benet, Leslie Z., Okochi, Hideaki, Wang, Guohong, Vincent, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428441/ https://www.ncbi.nlm.nih.gov/pubmed/30906930 http://dx.doi.org/10.1016/j.eclinm.2018.08.004

Ejemplares similares

Testing a Real-Time Tenofovir Urine Adherence Assay for Monitoring and Providing Feedback to Preexposure Prophylaxis in Kenya (PUMA): Protocol for a Pilot Randomized Controlled Trial
por: Drain, Paul, et al.
Publicado: (2020)

Urine Tenofovir Levels Measured Using a Novel Immunoassay Predict Human Immunodeficiency Virus Protection
por: Stalter, Randy M, et al.
Publicado: (2020)

Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing
por: Johnson, Kelly A, et al.
Publicado: (2021)

Tenofovir-Diphosphate in Dried Blood Spots vs Tenofovir in Urine/Plasma for Oral Preexposure Prophylaxis Adherence Monitoring
por: Niu, Xin, et al.
Publicado: (2022)

Antiretroviral Therapy Adherence During and Postbreastfeeding Cessation Measured by Tenofovir Levels in Hair
por: Nematadzira, Teacler G., et al.
Publicado: (2022)

Use of a risk scoring tool to identify higher-risk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention
por: Irungu, Elizabeth M., et al.
Publicado: (2016)

Diagnostic accuracy of a point‐of‐care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz‐based antiretroviral therapy
por: Dorward, Jienchi, et al.
Publicado: (2023)

A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET study
por: Cressey, Tim R., et al.
Publicado: (2017)

Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and Women
por: Pyra, Maria, et al.
Publicado: (2019)

Delivering safer conception services to HIV serodiscordant couples in Kenya: perspectives from healthcare providers and HIV serodiscordant couples
por: Ngure, Kenneth, et al.
Publicado: (2017)

Perceptions of pregnancy occurring among HIV-serodiscordant couples in Kenya
por: Kimemia, Grace, et al.
Publicado: (2019)

HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention
por: Donnell, Deborah, et al.
Publicado: (2014)

The Effect of Human Immunodeficiency Virus Prevention and Reproductive Health Text Messages on Human Immunodeficiency Virus Testing Among Young Women in Rural Kenya: A Pilot Study
por: Njuguna, Njambi, et al.
Publicado: (2016)

Effect of Depression on Adherence to Oral PrEP Among Men and Women in East Africa
por: Velloza, Jennifer, et al.
Publicado: (2018)

Perspectives on the utility and interest in a point-of-care urine tenofovir test for adherence to HIV pre-exposure prophylaxis and antiretroviral therapy: an exploratory qualitative assessment among U.S. clients and providers
por: Bardon, Ashley R., et al.
Publicado: (2020)

A Scoring Tool to Identify East African HIV-1 Serodiscordant Partnerships with a High Likelihood of Pregnancy
por: Heffron, Renee, et al.
Publicado: (2015)

The Incremental Cost of Delivering PrEP as a Bridge to ART for HIV Serodiscordant Couples in Public HIV Care Clinics in Kenya
por: Irungu, Elizabeth M., et al.
Publicado: (2019)

Feasibility and acceptability of HIV self-testing among pre-exposure prophylaxis users in Kenya
por: Ngure, Kenneth, et al.
Publicado: (2017)

Adherence determination using urine-tenofovir point-of-care testing and pharmacy refill records: A cross-sectional study
por: Herbertson, Ebiere C., et al.
Publicado: (2023)

Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption
por: Mugwanya, Kenneth K., et al.
Publicado: (2016)

Using Plasma Viral Load to Guide Antiretroviral Therapy Initiation to Prevent HIV-1 Transmission
por: Murnane, Pamela M., et al.
Publicado: (2012)

Urine Assay to Measure Tenofovir Concentrations in Patients Taking Tenofovir Alafenamide
por: Lalley-Chareczko, Linden, et al.
Publicado: (2020)

Adherence to recommendations for ART and targeted PrEP use among HIV serodiscordant couples in East Africa: the “PrEP as a bridge to ART” strategy
por: Musinguzi, Nicholas, et al.
Publicado: (2020)

Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women
por: Kourtis, Athena P., et al.
Publicado: (2017)

Patterns of PrEP continuation and coverage in the first year of use: a latent class analysis of a programmatic PrEP trial in Kenya
por: Mugwanya, Kenneth K., et al.
Publicado: (2023)

High Medication Adherence During Periconception Periods Among HIV-1–Uninfected Women Participating in a Clinical Trial of Antiretroviral Pre-exposure Prophylaxis
por: Matthews, Lynn T., et al.
Publicado: (2014)

The role of male partners in women’s participation in research during pregnancy: a case study from the partners demonstration project
por: Ngure, Kenneth, et al.
Publicado: (2017)

Design of a care pathway for pharmacy-based PrEP delivery in Kenya: results from a collaborative stakeholder consultation
por: Ortblad, Katrina F., et al.
Publicado: (2020)

Effect of 6-Month HIV Preexposure Prophylaxis Dispensing With Interim Self-testing on Preexposure Prophylaxis Continuation at 12 Months: A Randomized Noninferiority Trial
por: Ortblad, Katrina F., et al.
Publicado: (2023)

Impact of Tenofovir-Based Pre-exposure Prophylaxis on Biomarkers of Bone Formation, Bone Resorption, and Bone Mineral Metabolism in HIV-Negative Adults
por: Nickolas, Thomas L, et al.
Publicado: (2019)

Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by women in Kenya
por: Mugo, Nelly R., et al.
Publicado: (2023)

Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate‐Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy
por: Bukkems, Vera E., et al.
Publicado: (2020)

HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya
por: Ortblad, Katrina F., et al.
Publicado: (2019)

Process evaluation of PrEP implementation in Kenya: adaptation of practices and contextual modifications in public HIV care clinics
por: Irungu, Elizabeth M., et al.
Publicado: (2021)

Is Ciprofloxacin a Substrate of P-glycoprotein?
por: Park, Miki Susanto, et al.
Publicado: (2011)

Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1–Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda
por: Baeten, Jared M., et al.
Publicado: (2016)

Drug Synergy of Tenofovir and Nanoparticle-Based Antiretrovirals for HIV Prophylaxis
por: Chaowanachan, Thanyanan, et al.
Publicado: (2013)

Tenofovir substitution in Namibia based on an analysis of the antiretroviral dispensing database
por: Kalemeera, Francis, et al.
Publicado: (2015)

Dynamic Perceived HIV Risk and Sexual Behaviors Among Young Women Enrolled in a PrEP Trial in Kenya: A Qualitative Study
por: Ngure, Kenneth, et al.
Publicado: (2021)

PrEP as a Lifestyle and Investment for Adolescent Girls and Young Women in Sub-Saharan Africa
por: Haberer, Jessica E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3rlljm3fhg5bsuv2i6ileari7g